Li, Zirong
Liu, Yaoying
Shang, Xuying
Sheng, Huashan
Xie, Chuanbin
Zhao, Wei
Zhang, Gaolong
Zhou, Qichao
Xu, Shouping https://orcid.org/0000-0003-3189-9680
Funding for this research was provided by:
National Natural Science Foundation of China (No. 12375359)
Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2024-I2M-C&T-B-076)
Article History
Received: 21 August 2024
Accepted: 5 February 2025
First Online: 3 March 2025
Change Date: 29 November 2025
Change Type: Update
Change Details: The original online version of this article was revised: The institute name in the affiliation for Shouping Xu was corrected from 'National Clinical Research Center for Cancer' to 'National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital'.
Declarations
:
: The data used in the study was anonymized. They were following the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved with exemption from informed consent by the independent ethics committee of PLA General Hospital (approved no. S2016-122-01).
: Considering that the study was retrospective, obtaining consent from the patients was not applicable.
: The authors confirm that all participants agree to the publication of the study results.
: The authors declare that they have no conflict of interest.